NovaMedica is in advanced negotiations to secure Russia and CIS rights for a wide range of innovative Products. We are seeking specialty pharmaceutical drugs and devices from various potential US and European partners (including Domain Associates, Inc. portfolio companies) spanning several high-growth therapeutic areas in hospital inpatient, hospital outpatient and specialty care clinical contexts. Products can be both FDA/EMA approved and phase 2B/3 late-stage development. Please check back regularly as we grow our pipeline to serve this exciting market.
05 November 2024
03 November 2024
October 10 – World Mental Health Day
10 October 2024
news Innovating LNP design to improve mRNA therapeutics
25 November 2024
Siberian State Medical University and Skoltech to start production of bone tissue fillers
25 November 2024
Innovative method could address a major limitation in fluorescence microscopy
22 November 2024
Siberian State Medical University and Skoltech to start production of bone tissue fillers
22 November 2024